结果：沙美特罗替卡松粉剂明显改善哮喘病状。
Results: Salmeterol and fluticasone propionate powder marked improvement in asthma symptoms.
目的：观察沙美特罗替卡松儿童中度哮喘的临床疗效。
Objective: To explore the efficacy of seretide in treating childhood patients with moderate asthma.
结论沙美特罗替卡松干粉吸入能够改善慢性阻塞性肺疾病的肺功能。
Conclusion Salmeterol and fluticasone propionate inhalant can improve pulmonary function in COPD patients.
结论：沙美特罗替卡松治疗儿童哮喘的临床疗效较好，可以作为儿童哮喘的首选治疗。
Conclusions: therapy with seretide produces better results than other drugs and it was the first choice of therapy for childhood asthma.
结论：沙美特罗替卡松治疗哮喘，只要用量恰当，吸入的方法正确，可以减少哮喘发作的次数和减轻哮喘发作的程度。
Conclusion: The onset time and level of asthma can be decreased with proper dosage and inhalation method of Salmeterol fluticasone propionate.
目的探讨吸入沙美特罗-替卡松粉治疗慢性阻塞性肺疾病（COPD）的疗效。
Objective To evaluate the clinical effect of inhaling salmeterol-fluticasone on patients with COPD.
目的探讨吸入沙美特罗-替卡松粉治疗慢性阻塞性肺疾病（COPD）的疗效。
Objective To evaluate the clinical effect of inhaling salmeterol-fluticasone on patients with COPD.
应用推荐